A pathomics model for predicting response to chemo-immunotherapy in lung squamous cell carcinoma: A multicenter study
{{output}}
Background: The identification of lung squamous cell carcinoma (LUSC) patients who may benefit from first-line chemo-immunotherapy (CIT) remains a challenge. This study aimed to develop a pathomics model to predict the T cell-inf... ...
